CDASH Initiative. Dorothy Dorotheo Director, Clinical Data Management Intermune, Inc. Rhonda Facile Director CDASH Project, CDISC
|
|
- Elizabeth Lee
- 5 years ago
- Views:
Transcription
1 CDASH Initiative CDASH Project Update 6 December 2007 Bay Area User Group Dorothy Dorotheo Director, Clinical Data Management Intermune, Inc. Rhonda Facile Director CDASH Project, CDISC
2 CDISC Snapshot Global, open, multi-disciplinary non-profit organization Founded in 1997; incorporated in 2000 Nearly 200 member organizations Biopharmaceutical companies Academic Research Institutes Technology Vendors, etc Active Coordinating Committees Europe Japan Additional activities Australia India S. America and Africa Established industry standards to support the electronic acquisition, exchange, submission and archiving of data to support regulated clinical research Freely available on the CDISC website ( Developed through open, consensus-based approach 2
3 Clinical Data Acquistion Standards Harmonization Outline Background, Charter and the Collaborative Group (RF) CDISC COP 001 (RF) Project Organization (RF) Project Process (DD) Project Status (DD) SDTM and Terminology (DD) Practical Experience (DD) Next Steps (RF) Core Team Contact Info (RF) 3
4 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience Next Steps Core Team Contact Info 4
5 Background Critical Path Initiative #45; Build on work started by ACRO Jan DIA Open Forum Creating Clinical Trial Efficiencies Through Standard Data Collection organized by CDISC, FDA, ACRO CDISC requested to take leadership role as established standards development organization June 2006 Initial Collaborative Group (10) announced by Dr. Woodcock at Annual DIA Meeting in Philadelphia Human Subject Protection/Bioresearch Monitoring Initiative and Critical Path Update October 2006 Collaborative Project Kickoff, Cary N.C. 5
6 CDASH Project Charter CDASH = Clinical Data Acquisition Standards Harmonization Project Charter To develop a set of content standards (element name, definition, metadata) for a basic set of global industry-wide data collection fields that support clinical research. The initial scope will be the safety data/domains. These safety domains cut across all therapeutic areas, beginning with approximately domains. Follow CDISC Operating Procedure for Standards Development (COP-001). 6
7 Collaborative Group Role: To participate in the Collaborative Group Steering Committee, that provides expertise and strategic input to the CDASH Project Team and Streams. To contribute and/or help identify resources as deemed necessary to enable achievement of the mission, goals and deliverables for this project. 7
8 Collaborative Group: Provides expertise and strategic input into the CDASH Initiative Collaborative Group Members American Medical Informatics Association (AMIA) Association of Clinical Research Organizations (ACRO) Association of Clinical Research Professionals (ACRP) Baylor College of Medicine Biotechnology Industry Organization (BIO) Clinical Data Interchange Standards Consortium (CDISC) Clinical Research Forum Critical Path Institute Duke Clinical Research Institute (DCRI) Food and Drug Administration (FDA) National Institutes of Health (NIH) NCI-EVS NCI-caBIG Clinical Research Policy Analysis & Coordination Program National Clinical Research Resources (NCRR) National Institute of Child Health & Human Development (NICHD) Pharmaceutical Research and Manufacturers Association (PhRMA) Society for Clinical Data Management (SCDM) 8
9 Key Collaborations NIH NCI-EVS NCI-caBIG Clinical Research Policy Analysis & Coordination Program National Clinical Research Resources (NCRR) National Institute of Child Health & Human Development (NICHD) CDISC SDS Team CDISC Terminology Team 9
10 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience Next Steps Core Team Contact Info 10
11 CDISC Standards Development Process (COP-001) Primary Stages Stage I: Standard Definition/Approval Multidisciplinary Team Initiation; Working Plan Development Stage II: Standards Development-Consensus Model; s by External Focused Group and Open Public; Harmonization and Testing throughout; V1.0 Release Stage III: Education & Support Stage IV: Standards Update & Maintenance 11
12 Standards Development Process for CDISC (COP-001) Stage I: Standard Definition/Team Initiation Need for Specific Standard(s) Identified (any stakeholder) Proposal to Board of Directors (via OIS) per strategy, budget priorities Approved Team Leader ID And Team Formation (multidisciplinary) (OIS) Current Status Working Plan (timelines, deliverables communication mech., resources req d) (Team ) Not Approved Stage II: Standards Development//V 1.0 Release Consensus (Initial) TLC Harmonized OK Testing Comments addressed Ex Focused OK Public Released (Production) 1.0 Comments to address by team Stage III: Education & Support Respond To Comments And Questions Educational Programs (EDU, OIS) Stage IV: Standards Update & Maintenance Annual of Released (comments, chg reqsts, tests, plans) (Team) Working Plan (timelines, deliverables, communication mech., resources req d) (Team) Consensus (Revised) Optional SPCC Ex Focused Harmonized Public as needed Note: Occasional bug fix releases may be issued as needed with team review only. New Released (Production) 12
13 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience Next Steps Core Team Contact Info 13
14 CDASH Collaborative Group CDISC Technical Advisory Committee CDISC Technical Leadership Committee Core Team Stream Members 9 CDASH Streams (sub-groups) Comprised of ~190 volunteers 14
15 Project Organization Stream membership: Statisticians Medical Monitors/Clinical Scientists Regulatory Affairs Drug Safety Data Managers Clinical Study Coordinators Clinical Research Associates Investigators Clinical Program Managers Statistical Programmers Database programmers e Vendors Need more multi-national input! Participants in the CDASH Initiative Biotech 8% Other 18% Pharma 32% CROs 42% Other = Academic Research Organizations, Government (NIH, NCI), Hospitals, Universities. 15
16 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience Next Steps Core Team Contact Info 16
17 Process *Guiding principles: variables should Address either directly or indirectly SDTM required elements Be standard but flexible to allow customization within defined limits Limit variables to required and necessary Comply with regulatory requirements Reduce redundancies Increase collection of meaningful data Facilitate use of standards by all users Be appropriate for use both pre and post approval studies Allow consistent and efficient data collection/storage/transmission and analysis * ACRO s development principles, CDASH Kick-off Meeting, October 2006, Cary, N.C. 17
18 CDASH: Getting Started Start with Study Data Tabulated Model (SDTM) Data Variable Tables Refer to ACRO CRF Samples (where available) Initial Focus on CRF Content, not CRF Layout Collect CRF samples Evaluate commonalities/differences of CRF samples and SDTM Document data points included/excluded with justifications 18
19 Process Deliverables Reach agreement on basic CRF Data collection variables Map to SDTM - in cooperation with the SDTM development team Terminology Provide Terminology proposals to the Terminology team Add definitions Write completion guidelines/instructions Proceed to the next step in the Consensus Process as specified in COP- 001 Technical Leadership Committee (TLC) 19
20 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience Next Steps Core Team Contact Info 20
21 CDASH Package-1: Adverse Events, Concomitant Medication, Demographics & Subject Characteristics Oct launch at Project Kick-off meeting TLC and Collaborative Group (CG) reviews are completed CG comments are now being addressed and a ed achieved Consensus (Initial) TLC Harmonized OK Collaborative Group O K Public Released (Production)
22 Basic Data Collection Fields Identified: AE Adverse Event Term (*AETERM) Start Date (*AESTDTC) Stop Date (*AEENDTC) Seriousness (*AESER) Relationship (*AEREL) Action Taken (*AEACN) Outcome (*AEOUT) AE Severity (*AESEV) or AE Toxicity (*AETOXGR) CM Reported name of Drug, Medication or Therapy (*CMTRT) Start Date (*CMSTDTC) Stop Date (*CMENDTC) DM DM & SC Year Year of Birth of (*BRTHDTC) Birth (*BRTHDTC) Month Month of Birth of (*BRTHDTC) Birth (*BRTHDTC) Sex (*SEX) Sex (*SEX) Race Race of Subject of Subject (*RACE) (*RACE) Year of Birth (*BRTHDTC) Month of Birth (*BRTHDTC) Sex (*SEX) Race of Subject (*RACE) Optional data collection variables have also been identified. * Variable names are from the SDTM. 22
23 CDASH Package-2: Inclusion/Exclusion Criteria, Medical History & Substance Use, Physical Exam & Vital Signs Dec launch TLC and Collaborative Group (CG) reviews are completed CG comments are now being addressed and a ed achieved Consensus (Initial) TLC Harmonized OK Collaborative Group O K Public Released (Production)
24 CDASH Package-3: Drug Accountability & Exposure, Comments & Deviations, Disposition/End of Study Mar launch TLC review complete Collaborative Group review start December 5. Consensus (Initial) TLC Harmonized OK Collaborative Group O K Public Released (Production)
25 CDASH Package-4: Lab & ECG July 2007 Launch Lab ICV delivered now under TLC review ECG ICV due ASAP CG review planned for December 2007 Consensus (Initial) TLC Harmonized Collaborative Group O K Public Released (Production)
26 Initial Consensus TLC Harmonized Collaborative Group ed Public Released 1.0 Adverse Events Dec March 2007 May 2007 June-July 2007 Nov 2007 Q108 Q Prior & Concomitant Medication Jan 2007 April 2007 May 2007 June July 2007 Nov 2007 Q108 Q Demographics & Subject Characteristics Jan April 2007 May 2007 June July 2007 Nov 2007 Q108 Q Inclusion/Exclusion Criteria February 2007 May 2007 August 2007 Oct 2007 Oct-Nov 2007 Q108 Q Medical History and Substance Use February 2007 May 2007 August 2007 Oct 2007 Oct-Nov 2007 Q108 Q Physical Exam & Vital Signs February 2007 May 2007 August 2007 Oct 2007 Oct-Nov 2007 Q108 Q End of Study/ Disposition June 2007 Aug 2007 Nov 2007 Nov-Dec 2007 ongoing Dec 2007 Q108 Q Drug Accountability/ Exposure June 2007 Aug 2007 Nov 2007 Nov-Dec 2007 ongoing Dec 2007 Q108 Q Protocol Deviations/ Comments June 2007 Aug 2007 Nov 2007 Nov-Dec 2007 ongoing Dec 2007 Q108 Q Lab Oct Nov ongoing December 2007 Jan Feb Q108 Q ECG Nov Nov December 2007 Jan Feb Q108 Q
27 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience Next Steps Core Team Contact Info 27
28 FDA - Proposed Rule Federal Register / Volume 71, No. 237 / Monday, December 11, 2006 require (not just accept) electronic submissions require submissions to be in the SDTM format proposed 2 year implementation (actual proposed rule not yet written) 28
29 AE Relatedness Example AE Relatedness to Study Drug (CDISC AEREL, no standard codelist defined) Company 1 No Unlikely Possible Probably Definite Company 2 Not Related Doubtful Possible Very Likely Probable Company 3 NO YES / Unknown 29
30 SDTM Terminology Projects SDTM Package-1: 30 code lists & more than 700 controlled terms - Now in production Labtest: single code list with 92 controlled terms - Now in production 200 additional Analyte terms in development and available for public review Q SDTM Package-2A: 12 code lists & more than 600 controlled terms for ECG, Con Meds, Drug Exposure and Substance Use, including Units of Measure completed Public SDTM Package-2B: 17 code lists & 500+ controlled terms for AE, Physical Exam, Vital Signs and Subject Chars, including Anatomical Location in development 30
31 Harmonization Activities CDASH: aligning SDTM terminology projects with CDASH requirements full harmonization planned for Q CDASH = Questions Terminology = Answers 31
32 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience (DEMO) Next Steps Core Team Contact Info 32
33 1. ACRO Standard Form Practical Experience & Goal 4. Annotated Form + ODM Standard = Standard electronic metadata (XML) <ODM> <Study> <Meta </Meta </Study> </ODM> 3. ACRO Form + SDTM Standard = Annotated Form 5. Standard electronic metadata configures collection system 2. CDISC SDTM Standard 33
34 ACRO Adverse Event Form 34
35 Annotated 35
36 Electronic Configuration Courtesy of Assero 36
37 Electronic Configuration Courtesy of Formedix 37
38 Courtesy of XClinical 38
39 Courtesy of Outcome 39
40 Integrating the Healthcare Enterprise (IHE) Patient Care Coordinating Committee (PCCC) Electronic Health Records (EHR) Facilitate Single Source data entry. CDASH data collection elements to be used to create a profile, that can be used to populate a basic ecrf. 40
41 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status SDTM and Terminology Practical Experience Next Steps Core Team Contact Info 41
42 CDASH Project Standardize basic therapeutic area data variables (cooperate with other ongoing initiatives) Devices Imaging CDISC Supported Activities New Domains to be CDASHed Periodic update/revision of CDASH developed domains and documentation (Stage IV of COP-001) Training 42
43 Background, Charter and the Collaborative Group CDISC COP 001 Project Organization Project Process Project Status Practical Experience SDTM and Terminology Next Steps Core Team Contact Info 43
44 CDASH Project Process CDASH Core Team Contact Information Rhonda Facile Gary Walker Dorothy Dorotheo David E. Tatum Paul Bukowiec Trisha Simpson Shannon Labout Liz Nulton-Bodiford Jay Leeka Alec Vardy Kim Truett 44
45 CDASH Project Process Thanks to all the volunteers who have worked to get us where we are today. GET INVOLVED! contact Bron Kisler (Terminology): 45
46 Knowing is not enough; we must apply Willing is not enough; we must do Goethe 46
CDASH Clinical Data Acquisition Standards Harmonization
CDISC Italian User Group Meeting 16 November 2007 CDASH Clinical Data Acquisition Standards Harmonization 1 Outline Background Organization Goals Timelinesand Process Review of progress Results Future
More informationSan Diego CDISC User Group 3 November Emerging Device standards
San Diego CDISC User Group 3 November 2011 Emerging Device standards 1 CDISC Global, open, multi-disciplinary, vendorneutral, non-profit standards developing organization (SDO) Founded 1997, incorporated
More informationCDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008
CDISC Controlled Terminology across the Clinical Trial Continuum Bay Area Implementation Network 6 March 2008 Bron Kisler Co-Founder / Director of Terminology CDISC Terminology Initiative Overview / Background
More informationCDISC Standards: Current and Future
CDISC 2010 CDISC Standards: Current and Future CDISC Japan Interchange Tokyo, Japan 20 July 2010 Rebecca D. Kush, PhD President and CEO, CDISC Clinical Research Standards (Content) (Protocol-driven Research;
More informationCDISC Controlled Terminology: Let s Speak the Same Language
CDISC Controlled Terminology: Let s Speak the Same Language DCDISC User Network November 8, 2011 Chris Tolk Director, Terminology Agenda Overview / Objectives Key Drivers Terminology Development SDTMIG
More informationControlled Terminology
CDISC Italian User Group 16 November 2007 Controlled Terminology Cecilia Moresino Helsinn Healthcare Controlled Terminology A finite set of values that represent the only allowed values for a data item.
More informationCDISC Journal. Current status and future scope of CDISC standards. By Rebecca D. Kush, President and CEO, CDISC. 1. Introduction
CDISC Journal Clinical Data Interchange Standards Consortium oc tober 2012 Current status and future scope of CDISC standards By Rebecca D. Kush, President and CEO, CDISC 1. Introduction In translational
More informationOctober, Integration and Implementation of CDISC Standards
Integration and Implementation of CDISC Standards October, 2008 Barbara Lentz, Associate Director, Electronic Data Management Standards, Processes & Training Pat Majcher, Statistical Reporting Services
More informationA Brave New World: CDISC s New Therapeutic Area Standards for Clinical Research
A Brave New World: CDISC s New Therapeutic Area Standards for Clinical Research Authors: Kit Howard, Director of Education, CDISC Rhonda Facile, Sr. Director, TA Standards Development, CDISC 1 Agenda What
More informationCDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource
CDISC/TransCelerate Collaboration and TransCelerate work streams -Clinical Data Standards -Common Protocol Template -esource July 2016 TransCelerate Clinical Data Standards Project Opportunity
More informationCDISC Controlled Terminology: Let s Speak the Same Language. CDISC User Group Meeting March 12, 2009
CDISC Controlled Terminology: Let s Speak the Same Language CDISC User Group Meeting March 12, 2009 Agenda Key Terminology Objectives Key Drivers Terminology Production and Development Future Plans 2 Terminology
More informationCDISC End-to-End UK User Group Meeting GSK, Stockley Park 24 th October 2007 Dave Iberson-Hurst CDISC VP Technical Strategy CDISC 2007 Dave Iberson-Hurst CDISC VP Technical Strategy Co-lead Technical Advisory
More informationDisease Specific Data Standards: Case Studies in TB and Cardiology
CDISC 2010 Disease Specific Data Standards: Case Studies in TB and Cardiology CDISC Japan Interchange 20 July 2010 Bron Kisler bkisler@cdisc.org CDISC 2010 Presentation Outline Why disease-specific standards?
More informationThe use of electronic Health Records in Clinical Research - The value of CDISC Standards
The use of electronic Health Records in Clinical Research - The value of CDISC Standards FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria Who is Jozef Aerts? CDISC volunteer
More informationCDISC Global Update. President and CEO, CDISC
CDISC Global Update Rebecca D. Kush, PhD President and CEO, CDISC CDISC Advisory Board Program Committee CherylSimon* Peter Van Reusel* Gary Walker* Marcelina Hungria Dave Handelsman* Patrick Genyn* Sharon
More informationCDISC and Clinical Research Standards in the LHS
CDISC and Clinical Research Standards in the LHS Learning Health System in Europe 24 September 2015, Brussels Rebecca D. Kush, PhD, President and CEO, CDISC CDISC 2015 1 CDISC Healthcare Link Goal: Optimize
More informationTransCelerate BioPharma, Inc. Clinical Data Standards Project. Dave Jordan Data Standards Project Leader
TransCelerate BioPharma, Inc. Clinical Data Standards Project Dave Jordan Data Standards Project Leader 1 Outline TransCelerate Overview CFAST Overview Therapeutic Area Standards Project CDISC SHARE Q
More informationThe Evolution of SDTM
The Evolution of SDTM What s new? Tina Apers CRO Manager Mobile +32 476 60 08 79 tina.apers@businessdecision.com Business & Decision Life Sciences Tel +32 2 774 11 00 Fax +32 2 774 11 99 Sint-Lambertusstraat
More informationThe Transformation of Clinical Research. Health Information Technology Summit. Integration of Policy and Process with Information Technology
Health Information Technology Summit The Transformation of Clinical Research Integration of Policy and Process with Information Technology ehealth Initiative Washington October 22, 2004 Charles Jaffe,
More informationCDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017
CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017 CDISC 2017 1 Panelists Jim LaPointe Managing Director, Cambridge Semantics Patrick
More informationCDASH 2.0. Berlin Éanna Kiely CDISC Engineer
CDASH 2.0 Berlin Éanna Kiely CDISC Engineer 2016-09-13 Agenda CDASH 1.1 & CDASHIG 2.0 CDASH Concepts TAUG Examples Current Regulatory Perspective on CDASH Questions 2 CDASH: CDISC End to End Clinical Data
More informationCDISC Standards: Summary
Business Case for CDISC Standards: Summary PhRMA-Gartner-CDISC Project September 2006 Carol Rozwell, Gartner Rebecca Daniels Kush, CDISC Ed Helton, SAS Frank Newby, CDISC Tanyss Mason, CDISC Clinical Data
More informationCDISC Italian UN Aggiornamento/Attività
CDISC Italian UN Aggiornamento/Attività CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda Risposte Questionario Partecipanti CDISC in a
More informationData standardization and advancing regulatory science
Data standardization and advancing regulatory science Yoshiaki Uyama, Ph.D. Pharmaceuticals & Medical Devices Agency (PMDA) Visiting Professor, Graduate School of Medicine, Chiba University Visiting Professor,
More informationINTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING
INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING Wim Verreth 4 th Annual Outsourcing in Clinical Trials 21-22 May 2014 OUTLINE What is Clinical Automation? Why we
More informationCDISC User Group und PhUSE
CDISC User Group und PhUSE Rohrbacher Str. 26 69115 Heidelberg +49-6221-6051-0 Gemeinsamkeiten - Abgrenzung 5-September-2017 info@analytical-software.de CDISC and PhUSE Overview & General Principles CDISC
More informationPDUFA Update on Data Standards Institute of Medicine Workshop: Sharing Clinical Data
PDUFA Update on Data Standards Institute of Medicine Workshop: Sharing Clinical Data Mary Ann Slack Office of Planning and Informatics Center for Drug Evaluation and Research (CDER) U.S. Food and Drug
More informationUse and Evaluation of Standards for Investigator-Initiated Studies: Preliminary Results
Use and Evaluation of Standards for Investigator-Initiated Studies: Preliminary Results M. Theresa Perry RTRN (DTCC) 2010 AMIA Summit on Clinical Research Informatics March 12-13, 2010 Parc 55 Hotel San
More informationUsing CDASH data collection forms for automated SAE reporting
Using CDASH data collection forms for automated SAE reporting Andrew Newbigging Vice President, Integrations Development 21 st July 2010 Medidata Solutions, Inc. Proprietary - Medidata and Authorized Clients
More informationImplementation and Operation of CDISC ODM-based EDC by UMIN
Implementation and Operation of CDISC ODM-based EDC by UMIN Takahiro Kiuchi, M.D., Ph.D. UMIN Center, The University of Tokyo Hospital, Tokyo, Japan 1 Content 1. CDISC standards and academic research 2.
More informationTHE VISUALIZATION AND ANALYSIS OF IMMUNO-ONCOLOGY STUDIES USING JMP CLINICAL
THE VISUALIZATION AND ANALYSIS OF IMMUNO-ONCOLOGY STUDIES USING JMP CLINICAL GEOFFREY MANN, PHD JMP LIFE SCIENCES PRODUCT MANAGER GEOFFREY.MANN@JMP.COM BACKGROUND: IMMUNO- ONCOLOGY Immuno-Oncology studies
More informationCDISC Journal. Organizing and Accelerating the Clinical Research Process from the Beginning: The CDISC Protocol Representation Model and Toolkit
CDISC Journal Clinical Data Interchange Standards Consortium oc tober 2012 Organizing and Accelerating the Clinical Research Process from the Beginning: The CDISC Protocol Representation Model and Toolkit
More informationLOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017
LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017 Lauren Becnel, Ph.D. VP, Biomedical Informatics & Alliances, CDISC Asst Prof, Duncan Comprehensive Cancer Center,
More informationElectronic Data Submission and Utilization in Japan
PharmaSUG 2018 April 29 - May 2, Seattle, Washington Electronic Data Submission and Utilization in Japan Yuki Ando, PhD Senior Scientist for Biostatistics Office of Advanced Evaluation with Electronic
More informationPutting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay
How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay Jon Roth, Vice President, Data Sciences & Biometrics Authorized Trainer for ADaM, CDISC Mark Vieder,
More informationElectronic Health Records and Clinical Data Interchange Standards. Stephen E. Wilson, Dr.P.H., CAPT USPHS. Director. Division of Biostatistics III
Electronic Health Records and Clinical Data Interchange Standards Stephen E. Wilson, Dr.P.H., CAPT USPHS Director Division of Biostatistics III Center for Drug Evaluation and Research US Food and Drug
More informationPreclinical Data Standardization Process for regulatory submission to U.S. Food and Drug Administration
Preclinical Data Standardization Process for regulatory submission to U.S. Food and Drug Administration Gabriele Pesavento, 23 May 2018 Aptuit An Evotec company A full service CRO that delivers purpose
More informationExecutive Search. Chief Standards Officer
Executive Search Chief Standards Officer Client Overview Sterling Martin Associates has been retained by the Clinical Data Interchange Standards Consortium (CDISC) to search for Chief Standards Officer
More informationSAS SUPPORT CDISC AND CLINICAL METADATA MANAGEMENT BILL GIBSON SAS HLS GLOBAL PRACTICE PRINCIPAL PRODUCT MANAGER
SAS SUPPORT CDISC AND CLINICAL METADATA MANAGEMENT BILL GIBSON SAS HLS GLOBAL PRACTICE PRINCIPAL PRODUCT MANAGER OVERVIEW AND INTRODUCTION Abstract: SAS s current and future support of CDISC, such as possible
More informationThe Future of R&D Collaboration: Pre Competitive Collaboration in Clinical Trial Execution
The Future of R&D Collaboration: Pre Competitive Collaboration in Clinical Trial Execution An introduction to TransCelerate German CDISC UG Meeting Leverkusen Feb 26 th, 2013 Presentation Outline Background
More informationImplementing Clinical Trial Data Standards
Bernd Doetzkies, Director Informatics Daiichi Sankyo Pharma Development PRISME Forum SIG Meeting 17Oct2011 Implementing Clinical Trial Data Standards Clinical Development Business Trends Resistance to
More informationDISCOVER DEFINE- XML PRACTICAL USES END-TO-END TODAY Mark Wheeldon CEO Formedix Bay Area User Group May 23, 2013
DISCOVER DEFINE- XML PRACTICAL USES END-TO-END TODAY Mark Wheeldon CEO Formedix Bay Area User Group May 23, 2013 AGENDA Introduction Your Clinical Trials Automated. Everywhere. Define Driven Dataset Libraries
More informationMANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners
MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical
More informationPharmaSUG 2017 Paper DS14
PharmaSUG 2017 Paper DS14 Considerations in Submitting Standardized Electronic Data Under the Animal Rule: The Use of SDTMIG and SENDIG Domains, and the Need for New Domains and Concepts Fred Wood, Accenture
More informationStandardize Study Data for Electronic Submission
PharmaSUG China 2018 - Paper CD-43 ABSTRACT Standardize Study Data for Electronic Submission Qin Li, Regeneron Pharmaceuticals Inc. In December 2014, FDA announced that submissions under NDAs, ANDAs, BLAs,
More informationCDISC Customer Requirements Analyses
Data Model Customer Requirements Analyses Copyright 2003 About The Clinical Data Interchange Standards Consortium () is an open, multidisciplinary, non-profit organization committed to the development
More information2016 Technical Update. August 2016
2016 Technical Update August 2016 1 Foundational Standards Key Milestones CTR ODM XML Modernize CT Process CDISC Protocol Standards IntraChange Cross-team focus Survey CTR Content Governance: Consistent
More informationClinical Data Acquisition Standards Harmonization (CDASH)
Clinical Data Acquisition Standards Harmonization () Prepared by: CDISC Team Section Table of Contents Page 1.0 Orientation... 1 1.1 Purpose... 1 1.2 Organization of this Document... 1 1.2.1 General Notes...2
More informationEvolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network
Evolving Regulatory Guidance on Submission of Standardized Data James R. Johnson, PhD RTP CDISC User Network 2014-06-11 Originally Presented at PhUSE Conference 2013 Brussels, Belgium (Paper Number: RG03)
More informationmedicines, improving the health of people around the world.
TransCelerate BioPharma Inc. is a non-profit organization with a mission to collaborate across the biopharmaceutical research and development community to identify, design and facilitate the implementation
More informationIntegration of EHRs with CDISC, CDASH and ODM A European Initiative
Budapest, Hungary 22nd 23rd April 2009 Session 2 11:00-12:30 European perspective of EHR integration Chair: Udo Siegmann (Parexel) Integration of EHRs with CDISC, CDASH and ODM A European Jozef Aerts XML4Pharma
More informationAdvanced workflow of review/consultation
PMDA Update Yuki Ando, PhD Senior Scientist for Biostatistics Advanced Review with Electronic Data Promotion Group Pharmaceuticals and Medical Devices Agency CDISC 2016 1 Advanced workflow of review/consultation
More informationElectronic Health Records and Clinical Data Interchange Standards
Electronic Health Records and Clinical Data Interchange Standards Stephen E. Wilson, Dr.P.H., CAPT USPHS Director Division of Biostatistics III Center for Drug Evaluation and Research US Food and Drug
More informationHarnessing the power of clinical data
Harnessing the power of clinical data Harnessing the power of clinical data Managing the data burden Life sciences companies are rich in data and gaining exponentially more clinical data all the time.
More information2010 CDISC Japan Interchange
2010 6 28 2010 CDISC Japan Interchange Japan CDISC Coordinating Committee (J3C) Chair 2010 7 20 7 23 4 7 20 21 7 22 23 102-0093 2-4-1 Tel 03-3265-8211 http://www.toshicenter.co.jp CDISC http://www.cdisc.org/interchange
More informationIt s All About The RISK
Session Q 2: esource Document Verification A Case for CRF Mapping Glenda Guest It s All About The RISK What are some of the realized risks that auditors are observing? Multiple sources, how to ensure consistency
More informationADB Consulting & CRO Inc.
DATA MANAGEMENT, BIO-STATISTICS, CLINICAL OPERATIONS, QUALITY SYSTEMS & STAFFING SERVICES Abbreviated Edition December 2005 Advancing Data Management, Bio-statistics, Clinical Operations, & Quality Systems
More informationFrom Standards that Cost to Standards that Save: Cost Effective Standards Implementation
From Standards that Cost to Standards that Save: Cost Effective Standards Implementation Jeffrey M. Abolafia, Rho, Chapel Hill, NC Frank DiIorio, CodeCrafters Inc., Philadelphia, PA Warning This presentation
More informationSDTM and SEND An Integrated View and Approach
SDTM and SEND An Integrated View and Approach PhUSE Connect 2018 Veena Nataraj Cheryl Riel Overview Nonclinical and Clinical Development Phase Regulatory Agency Needs Deliverables to Regulatory Agencies
More informationMIT Information Quality Industry Symposium, July 16-17, Data Integration and Data Quality: Pharmaceutical Industry Case.
Data Integration and Data Quality: Pharmaceutical Industry Case. Sergiy Sirichenko, Vadim Tantsyura, Olive Yuan, Ph.D. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY) Max Kanevsky (Pinnacle21, Plymouth
More informationCDISC Journal. Genzyme s GetSMART Program: Implementing Standards End-to-End
CDISC Journal Clinical Data Interchange Standards Consortium O ctober 2011 Genzyme s GetSMART Program: Implementing Standards End-to-End By Sue Dubman, Brooke Hinkson, Dana Soloff, David Fritsche and PK
More informationReport from the EHR Clinical Research Tiger Team
Document Number: 09 N 403 Date: June 1, 2009 Report from the EHR Clinical Research Tiger Team June 1, 2009 Presented by: Walter Suarez, MD, MPH Tiger Team Co-Chair enabling healthcare interoperability
More informationBreakout session notes CDISC UK Network Face to Face meeting June 23 rd 2015
Breakout session notes CDISC UK Network Face to Face meeting June 23 rd 2015 Questions that came up during the breakout sessions are colour-coded: Blue questions that were answered during the session,
More informationXClinical Software & Services Fast - Flexible - Focused
Fact Sheets XClinical Software & Services Fast - Flexible - Focused XClinical offers an integrated range of software products for CROs, pharmaceutical, medical device and biopharmaceutical companies. Our
More informationClinical Data Standards & Automation
Clinical Data Standards & Automation PhUSE 2007 Author: Giri Balasubramanian Company Name: Kinship Technologies Pvt. Ltd., Table of Contents EXECUTIVE SUMMARY... 3 1.0 INTRODUCTION... 4 2.0 WHY AUTOMATION?...
More informationStatistician s secret weapon: 20 ways of detecting raw data issues
SESUG Paper DM-171-2017 Statistician s secret weapon: 20 ways of detecting raw data issues Lixiang Larry Liu, Eli Lilly and Company, Indianapolis, IN ABSTRACT Unclean clinical raw data is always statistician
More informationREQUEST FOR PROPOSAL. Statistical Programing Expert Crohn s Disease Therapeutic Area User Guide. October 2018
REQUEST FOR PROPOSAL Statistical Programing Expert Crohn s Disease Therapeutic Area User Guide - SPONSOR: CDISC October 2018 1 Contents Executive Summary... 3 Project Description... 3 Task Description...
More informationHigh Quality or Poor Quality DB
The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. ( DIA ), its directors, officers,
More informationCDISC International Interchange Program Embracing a Changing Landscape Standards to Connect Research and Patient Care
CDISC International Interchange Program Embracing a Changing Landscape Standards to Connect Research and Patient Care B e t h e s d a N o r t h M a r r i o t t H o t e l a n d C o n f e r e n c e C e n
More informationSAS Life Science Analytics Framework
CDISC Italian User Network Day 21Oct2016 (Data standard e loro applicazione) SAS Life Science Analytics Framework STIJN ROGIERS - SAS SENIOR INDUSTRY CONSULTANT GLOBAL PRACTICE, HEALTH & LIFE SCIENCES
More informationCDISC Production Standards Status & Plans
Bay Area User Network CDISC Production Standards Status & Plans Wayne R. Kubick Sr. Vice President, Lincoln Technologies CDISC Technical Director SDS Team Leader Agenda Topics The role and work of the
More informationJanus Clinical Trials Repository: Modernizing the Review Process through Innovation
Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Lilliam Rosario, Ph.D. Director Office of Computational Science Food and Drug Administration Janus Clinical Trials Repository
More informationGood Clinical Practice (GCP) & Clinical Trial Registries
Good Clinical Practice (GCP) & Clinical Trial Registries The Fifth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practice Forum November 14-17, 2004 Kate Maloney, RN, MS, CPHQ Manager,
More informationSupporting A Data Review and Visualization Application With SDTM
Paper DV09 Supporting A Data Review and Visualization Application With SDTM Deepika Sunkara, MS, Covance, King of Prussia, Pennsylvania Jagadish Dhanraj, MS, Medimmune, Gaithersburg, Maryland ABSTRACT
More informationEnd-to-End Management of Clinical Trials Data
End-to-End Management of Clinical Trials Data A Revolutionary Step Toward Supporting Clinical Trials Analysis Over the Next Decades of Clinical Research WHITE PAPER SAS White Paper Table of Contents Introduction....
More informationMultifaceted aspects of metadata maximize efficiencies
Multifaceted aspects of metadata maximize efficiencies May 10 th, 2012 Patrick Genyn, Senior Director Drug Development Information Governance 9th Annual SAS Health Care & Life Sciences Executive Conference
More informationemerge Data Dictionary Harmonization and Best Practices for Standardized Phenotype Data Representation Jyoti Pathak April 13 th, 2010
emerge Data Dictionary Harmonization and Best Practices for Standardized Phenotype Data Representation Jyoti Pathak April 13 th, 2010 Chris Chute Dan Masys Janey Wang Sudha Kashyap Melissa Basford Acknowledgment
More informationPublic-Private Partnerships to Support Pediatric Trials. Pediatric Trials Consortium
Public-Private Partnerships to Support Pediatric Trials Pediatric Trials Consortium Ed Connor, MD MBE Executive Director and Scientific Lead April 2016 IMPRESSIVE HISTORY OF PEDIATRIC LEGISLATION US FADASIA
More informationSAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China
PharmaSUG China 2015 - Paper 29 SAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China ABSTRACT Are you in trouble with executing timely queries against historical or ongoing clinical
More informationFDASmart Inc. EDC & CDM Solutions
FDASmart Inc. EDC & CDM Solutions Our Services Validation of EDC Products as per Client Requirement with compliance with FDA s CFR 21 Part 11 Training on EDC Rave Helps to prepare SOPs and SWIs related
More informationIndustrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence
Industrialized Clinical Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Executive Summary The majority of commercially available legacy
More informationBIOMETRICS SERVICES ADVISORY DATA OFFICE UNBLINDING SECURE INDEPENDENT TEAM PROGRAM. ADaM TRAINER SAFETY SDTM COMPLIANT TA-EXPERTISE SDTM DATA
BIOMETRICS SERVICES DELIVER UNBLINDED DATASETS TO IDMC SDTM-IG UNBLINDING ADVISORY QUALITY ON TIME DEDICATED DATA SECURE BOARD EMERGENCY PARTNERSHIPTEAM DATA OFFICE UNBLINDING INVESTINGEXPERTISE SHARING
More information9th Annual SAS Health Care & Life Sciences Executive Conference
: An Integrated Platform to Promote Data Exchange, Collaboration, and Advanced Analytics 9th Annual SAS Health Care & Life Sciences Executive Conference 9-10 May 2012 Bernd Doetzkies, Director Informatics
More informationClinical Data Management Services
Clinsoft Overview Clinical Trial Management Clinical Data Management Services Medical Writing & Pharmacovigilance Services 2 Overview Started in 2008 with a small group of 7 team members. Expanded to a
More informationChapter 1. Pharmaceutical Industry Overview
Chapter 1 Pharmaceutical Industry Overview 1.1 Introduction 2 1.2 Regulations 2 1.2.1 Health Insurance Portability and Accountability Act 2 1.2.2 The Code of Federal Regulations 3 1.2.3 Guidance for Industry
More informationOptimize Your Medical Affairs Team s Influence in a Start-up Organization
Optimize Your Medical Affairs Team s Influence in a Start-up Organization Rachel Couchenour, PharmD, MBA Sr. Director, Medical Affairs Mateon Therapeutics Objectives Discover the unique challenges faced
More informationClinical Data Standards Governance. Tammy Burns, Expert Clinical Data Manager 11 th January 2013
Clinical Data Standards Governance Tammy Burns, Expert Clinical Data Manager 11 th January 2013 Standards Used and Formal Govenance Standard Types General and Therapeutic Area Data Standards Collection
More informationOptimizing Your Study Data Submissions to FDA Updates from CDER and CBER
This single PDF file contains the slides for all three presentations in the webinar: Optimizing Your Study Data Submissions to FDA Updates from CDER and CBER Please page down to find the slides for all
More informationStatistical Review and Data Standards: It s Gettin Better All The Time
Statistical Review and Data Standards: It s Gettin Better All The Time Steve Wilson, Dr.P.H., CAPT USPHS Office of Biostatistics FDA/OMPT/CDER 2017 PharmaSUG Baltimore, MD May 17, 2017 Disclaimer This
More informationOpen Source Technologies for Clinical Trials. Innovative Solutions to Overcome Current Challenging Climate
Innovative Solutions to Overcome Current Challenging Climate Introduction Clinical trials have become increasingly complex and, as a result, costly. Only 333 drugs and biologics have been approved between
More informationUsing SAS ETL Studio to Convert Clinical Trials Data to the CDISC SDTM Barry R. Cohen, Octagon Research Solutions, Wayne, PA
Paper FC04 Using SAS ETL Studio to Convert Clinical Trials Data to the CDISC SDTM Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT A new industry standard for clinical and preclinical trials
More informationCDISC Data Standards Validation
CDISC Data Standards Validation How can it be done? Peter Van Reusel Business Unit Director Business & Decision Life Sciences Tel +32 2 774 11 00 Fax +32 2 774 11 99 Mobile +32 476 54 59 17 peter.vanreusel@businessdecision.com
More informationThe Role of Medical Research in the Learning Health System or Vice Versa
The Role of Medical Research in the Learning Health System or Vice Versa Rebecca D. Kush, PhD; President and CEO, CDISC Joseph H. Kanter Family Foundation & Kanter Foundation Annual Meeting 24 March 2016
More informationSteps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition
Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition David Izard, MS Terek Peterson, MBA Richard Addy, MS CDISC ODM SDTM LAB CDASH ADaM PRM SEND Controlled
More informationChair of the TMF Reference Model Steering Committee Co-founder of the TMF Reference Model with Lisa Mulcahy Chief Strategy Officer, Phlexglobal
Karen Roy Chair of the TMF Reference Model Steering Committee Co-founder of the TMF Reference Model with Lisa Mulcahy Chief Strategy Officer, Phlexglobal Paul Fenton Co-chair of the TMF Reference Model
More informationCDISC UK Network face to face Reading
CDISC UK Network face to face Reading Paul Houston, CDISC Head of European Operations CDISC Update and European Activity 2 CDISC Values and Principals Core value Foster CDISC community is altruistic
More informationThe Anatomy of Clinical Trials Data: A Beginner s Guide
ABSTRACT Paper 1759-2018 The Anatomy of Clinical Trials Data: A Beginner s Guide Venky Chakravarthy, BioPharma Data Services, Ann Arbor, Michigan An audience that wants to learn more about clinical trials
More informationPhUSE Paper PP07. EPOCH in Reverse. Ann Croft, LEO Pharma, Hurley, UK
Paper PP07 EPOCH in Reverse Ann Croft, LEO Pharma, Hurley, UK ABSTRACT After supplying test data through the electronic gateway to the FDA, LEO Pharma was informed that the FDA required some updates to
More informationCLINICAL DATA MANAGEMENT
CLINICAL DATA MANAGEMENT Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection, cleaning
More information